BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

ACOG

Alpha Cognition Inc.
Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Dec

Revenue, quarterly

$6M+267.6% year on year
$8M$5M$3M$0
Q1 ’25Q2 ’25Q4 ’25Q1 ’26Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

93.6%
95%94%93%92%
Q4 ’25Q1 ’26Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$41M+5.0% year on year
$75M$50M$25M$0
Q3 ’24Q1 ’25Q3 ’25Q4 ’25Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$31M
$20M$0−$20M−$40M
Q4 ’25Q1 ’26Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty